C Reinheimer1, R Allwinn, H W Doerr. 1. Institute for Medical Virology, J.W. Goethe University Hospital, 60596, Frankfurt am Main, Germany.
Abstract
BACKGROUND: The intention of our investigation was to determine the seroprevalence of H1N1v antibodies after a pandemic by the haemagglutination inhibition (HI) test. We included the serum samples of adults who had not received vaccination against H1N1v. By means of serological footprints, the spread of infection can be investigated. MATERIALS AND METHODS: Between December 2009 and May 2010, we collected 233 serum samples from healthy people aged 1-72 years and analysed the titres of H1N1v antibodies by the use of the HI test. RESULTS: After the pandemic, a seroprevalence of 36.9% was observed. The highest rate of seropositivity was detected in the age group of 10-19 years (60%) and the lowest rate was found in the age group of 30-39 years (22%). The seroprevalence of H1N1v antibodies in females exceeded the rate of positive men (41.5 vs. 31.8%). Almost 70% of the influenza A/H1N1v infections were passed inapparently.
BACKGROUND: The intention of our investigation was to determine the seroprevalence of H1N1v antibodies after a pandemic by the haemagglutination inhibition (HI) test. We included the serum samples of adults who had not received vaccination against H1N1v. By means of serological footprints, the spread of infection can be investigated. MATERIALS AND METHODS: Between December 2009 and May 2010, we collected 233 serum samples from healthy people aged 1-72 years and analysed the titres of H1N1v antibodies by the use of the HI test. RESULTS: After the pandemic, a seroprevalence of 36.9% was observed. The highest rate of seropositivity was detected in the age group of 10-19 years (60%) and the lowest rate was found in the age group of 30-39 years (22%). The seroprevalence of H1N1v antibodies in females exceeded the rate of positive men (41.5 vs. 31.8%). Almost 70% of the influenza A/H1N1v infections were passed inapparently.
Authors: John C Obenauer; Jackie Denson; Perdeep K Mehta; Xiaoping Su; Suraj Mukatira; David B Finkelstein; Xiequn Xu; Jinhua Wang; Jing Ma; Yiping Fan; Karen M Rakestraw; Robert G Webster; Erich Hoffmann; Scott Krauss; Jie Zheng; Ziwei Zhang; Clayton W Naeve Journal: Science Date: 2006-01-26 Impact factor: 47.728
Authors: Ted Ross; Shanta Zimmer; Don Burke; Corey Crevar; Donald Carter; James Stark; Brendan Giles; Richard Zimmerman; Stephen Ostroff; Bruce Lee Journal: PLoS Curr Date: 2010-02-24
Authors: Elizabeth Miller; Katja Hoschler; Pia Hardelid; Elaine Stanford; Nick Andrews; Maria Zambon Journal: Lancet Date: 2010-01-21 Impact factor: 79.321
Authors: Kathy Hancock; Vic Veguilla; Xiuhua Lu; Weimin Zhong; Eboneé N Butler; Hong Sun; Feng Liu; Libo Dong; Joshua R DeVos; Paul M Gargiullo; T Lynnette Brammer; Nancy J Cox; Terrence M Tumpey; Jacqueline M Katz Journal: N Engl J Med Date: 2009-09-10 Impact factor: 91.245
Authors: D Roll; J Ammer; B Holler; B Salzberger; B Schweiger; W Jilg; R Andreesen; M Edinger; D Wolff; E Holler Journal: Infection Date: 2011-10-29 Impact factor: 3.553